Evidence map›Paper›PMID 40936979›Full record

ArticlePublic health action2025

Decentralising DR-TB care: the trade-off between quality of care and service coverage in the early phase of implementation.

W Jassat, M Moshabela, M P Nicol, L Dickson, H Cox, K Mlisana, J Black, M Loveday, A D Grant, K Kielmann and 1 more

Abstract read
In one paragraph

Article in Public health action, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

W JassatTB Control and Management Cluster, National Department of Health, Pretoria, South Africa.ORCID https://orcid.org/0000-0003-4279-3056
M MoshabelaSchool of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
M P NicolMarshall Centre, Division of Infection and Immunity, School of Biomedical Sciences, University of Western Australia, Perth, Australia.
L DicksonMarshall Centre, Division of Infection and Immunity, School of Biomedical Sciences, University of Western Australia, Perth, Australia.
H CoxDivision of Medical Microbiology, University of Cape Town, Cape Town, South Africa.
K MlisanaSchool of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
J BlackDivision of Infectious Diseases, Department of Medicine, University of Cape Town, Cape Town, South Africa.
M LovedayHIV and other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa.
A D GrantTB Centre, London School of Hygiene & Tropical Medicine, London, UK.
K KielmannInstitute for Global Health & Development, Queen Margaret University, Edinburgh, Scotland, UK.
H SchneiderSchool of Public Health and SAMRC Health Services to Systems Research Unit, University of the Western Cape, Cape Town, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA policy of decentralised care for drug-resistant TB (DR-TB) was introduced in South Africa in 2011. We describe a trade-off between increasing coverage of services and poor quality of care, in the early phase of policy implementation.

methodsThis was a mixed methods case study, comparing implementation in KwaZulu-Natal and Western Cape provinces; with interviews and quantitative analysis of routine DR-TB programme data. We analysed qualitative data, thematically organizing findings into inputs, processes, and outputs to explore how decentralisation influenced quality of DR-TB care.

resultsDecentralisation of DR-TB care expanded access across provinces but there was wide variation in pace, planning and structural readiness. Where rapid scale-up outpaced capacity-building, weaknesses in resourcing, workforce, and clinical governance compromised quality of care. Two illustrative examples highlight that decentralisation to inadequately resourced sites resulted in morbidity to patients who did not receive effective monitoring for adverse events; and decentralising services to inadequately capacitated clinicians resulted in incorrect initiation in more complex cases and late referral of clinical complications.

conclusionsAttempts to decentralise DR-TB treatment in the context of complex treatment algorithms and limited health system capacity resulted in trade-offs of care quality. We argue that quality of care should be an essential consideration in early implementation of health programmes.

Indexed as

health system capacityKwaZulu-NatalSouth AfricatuberculosisWestern Cape

Identifiers

PMID40936979
PMCPMC12421840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.